TSUKAMOTO Norifumi

J-GLOBAL         Last updated: Jan 11, 2020 at 02:44
 
Avatar
Name
TSUKAMOTO Norifumi
Affiliation
Gunma University
Job title
Associate Professor
Degree
(BLANK)(Gunma University)

Research Areas

 
 

Academic & Professional Experience

 
1994
 - 
1996
Research Fellow, City of Hope Medical Center
 

Education

 
 
 - 
1984
Faculty of Medicine, Toyama Medical and Pharmaceutical University
 

Misc

 
Maintenance and Characterization of an Epstein Barr Virus-infected CD56-negative T Cell Lymphoma.
Maekawa I, Saitoh H, Aoki N, Morishita Y, Tsukamoto N, Karasawa M, Nonaka Y, Shiota M, Nojima Y, Mori S.
Jpn J Cancer Res.   93(1) 61-69   2002
Saito Y, Matsushima T, Koki N Tsumita Y, Takizawa M, Yokohama A, Handa H, Tsukamoto N, Karasawa M, Murakami H, Nojima Y
Eur J Haematol   75(1) 65-67   2005
Hatsumi N, Saitho T, Yokohama A, UCHIUMI H, MATSUSHIMA T, TSUKAMOTO N, KARASAWA M, NOJIMA Y, Handa H, OGAWARA H, Murakami H
Ultrastructural Pathology   26 415-417   2002
OGAWARA HATSUE / HANDA HIROSHI / KANEKO YORIAKI / TSUKAMOTO NORIFUMI / MURAKAMI HIROKAZU / NOJIMA YOSHIHISA
Eur J Haematol.   71(4) 283-288   2003
YOKOHAMA AKIHIKO / TSUKAMOTO NORIFUMI / UCHIUMI HIDEKI / HANDA HIROSHI / MATSUSHIMA TAKAFUMI / KARASAWA MASAMITSU / MURAKAMI HIROKAZU / NOJIMA YOSHIHISA
Ann Hematol.   26    2003

Conference Activities & Talks

 
Clinical significance of Th1/Th2 ratio in patients with multiple myeloma
XVIth International Symposium on Technical Innovations in Laboratory Hematology   2003   
Coagulopathy in HLA-DR antigen-negative acute myeloid leukemia
American Society of Hematology, 46th Annual Meeting   2004   
Prognostic impact of VH gene mutational status and CD38 expression in Japanese CLL patients
American Society of Hematology, 46th Annual Meeting   2004   
High Th1/Th2 ratio in patients with multiple myeloma
American Society of Hematology, 44th Annual Meeting   2002   
IL-10 promoter resion -592A/C genotype increases the risk of myeloma in Japanese patients.
American Society of Hematology, 48th Annual Meeting   2006   

Works

 
Enhanced expressions of glucose-6-phosphate dehydrogenate and cytosolic aldehyde dehydrogenate and elevation of reduced glutathione level in cyclophosphamide -resistant leukemia cells.
1998